•  
  •  
 

ORCID ID

Yousef Saad Aldabayan: 0000-0001-5879-8025

Antonieto Alaban: 0000-0001-5879-8025

Eduardo Fabella: 0000-0001-6762-4983

Amal Ismael Aldelhafez: 0000-0002-2416-284

Abstract

Background: This study was conducted to estimate the proportion of patients who experience a high impact from chronic obstructive pulmonary disease (COPD) on their health status and those who also experience symptoms of depression and anxiety. It also sought to determine whether the health impact of the disease is associated with anxiety and depression.

Methods: An analytical cross-sectional study was conducted among 177 randomly selected patients with COPD seeking treatment in various primary health centers in Al Ahsa, Saudi Arabia. The COPD Assessment Test (CAT) was used to determine the impact of COPD on health generally, and the Hospital Anxiety and Depression Scale was used to determine the presence of anxiety and depression symptoms. Multiple logistic regression was performed to determine the association between the health impact of COPD on the respondents and the presence of symptoms of anxiety and depression.

Results: Patients who had a CAT Score of >21 were 17.37 times more likely to experience anxiety. Patients with COPD who had a CAT Score of >21 were 5.62 times more likely to experience depression.

Conclusion: COPD had a severe impact on the health of nearly 30% of the patients affected. The high impact of COPD on health increases the likelihood of having anxiety and depression symptoms.

References

  1. Halpin DMG, Celli BR, Criner GJ, Frith P, López Varela MV, Salvi S, et al. The GOLD Summit on chronic obstructive pulmonary disease in low- and middle-income countries. Int J Tuberc Lung Dis. 2019;23:1131–41.
  2. Meghji J, Mortimer K, Agusti A, Allwood BW, Asher I, Bateman ED, et al. Improving lung health in low-income and middle-income countries: From challenges to solutions. Lancet. 2021;397:928–40.
  3. GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020;8:585–96.
  4. World Health Organization. Chronic obstructive pulmonary disease (COPD). Geneva: World Health Organization, 2023.
  5. Celli B, Fabbri L, Criner G, Martinez FJ, Mannino D, Vogelmeier C, et al. Definition and nomenclature of chronic obstructive pulmonary disease: Time for its revision. Am J Respir Crit Care Med. 2022;206:1317–25.
  6. Alqahtani JS. Prevalence, incidence, morbidity and mortality rates of COPD in Saudi Arabia: Trends in burden of COPD from 1990 to 2019. PLoS One. 2022;17:e0268772.
  7. Al Ghobain M, Alhamad EH, Alorainy HS, Al Kassimi F, Lababidi H, Al-Hajjaj MS. The prevalence of chronic obstructive pulmonary disease in Riyadh, Saudi Arabia: A BOLD study. Int J Tuberc Lung Dis. 2015;19:1252–7.
  8. Torres-Sánchez I, Cabrera-Martos I, Díaz-Pelegrina A, Valenza-Demet G, Moreno-Ramírez MP, Valenza MC. Physical and functional impairment during and after hospitalization in subjects with severe COPD exacerbation. Respir Care. 2017;62:209–14.
  9. Patel JG, Coutinho AD, Lunacsek OE, Dalal AA. COPD affects worker productivity and health care costs. Int J Chron Obstruct Pulmon Dis. 2018;13:2301–11.
  10. Rai KK, Adab P, Ayres JG, Jordan RE. Systematic review: Chronic obstructive pulmonary disease and work-related outcomes. Occup Med (Lond). 2018;68:99–108.
  11. Getahun B, Bekel AA. Work-related Chronic Obstructive Pulmonary Disease. In: Ong KC. Ed. Chronic Obstructive Pulmonary Disease - A Current Conspectus. London, UK: IntechOpen, 2021.
  12. Poucineau J, Delory T, Lapidus N, Hejblum G, Chouaïd C, Le Cœur S, et al. Hospital admissions and mortality for acute exacerbations of COPD during the COVID-19 pandemic: A nationwide study in France. Front Med (Lausanne). 2022;9:995016.
  13. Kim Y, Kim K, Rhee CK, Ra SW. Increased hospitalizations and economic burden in COPD with bronchiectasis: A nationwide representative study. Sci Rep. 2022;12:3829.
  14. Kong CW, Wilkinson TMA. Predicting and preventing hospital readmission for exacerbations of COPD. ERJ Open Res. 2020;6:00325–2019.
  15. Alwafi H, Naser AY, Ashoor DS, Aldhahir AM, Alqahtani JS, Minshawi F, et al. Trends in hospital admissions and prescribing due to chronic obstructive pulmonary disease and asthma in England and Wales between 1999 and 2020: An ecological study. BMC Pulm Med. 2023;23:49.
  16. López-Pardo ME, Candal-Pedreira C, Valdés-Cuadrado L, Represas-Represas C, Ruano-Ravina A, Pérez-Ríos M. Factors related with hospital attendance and mortality in patients with COPD: A case-control study in a real-life setting. Int J Chron Obstruct Pulmon Dis. 2022;17:809–19.
  17. MacIntyre NR. Toward reducing COPD hospitalization. Respir Care. 2020;65:127–8.
  18. Mei F, Dalmartello M, Bonifazi M, Bertuccio P, Levi F, Boffetta P, et al. Chronic obstructive pulmonary disease (COPD) mortality trends worldwide: An update to 2019. Respirology. 2022;27:941–50.
  19. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186:155–61.
  20. Pascal OI, Trofor AC, Lotrean LM, Filipeanu D, Trofor L. Depression, anxiety and panic disorders in chronic obstructive pulmonary disease patients: Correlations with tobacco use, disease severity and quality of life. Tob Induc Dis. 2017;15:23.
  21. Yohannes AM, Alexopoulos GS. Depression and anxiety in patients with COPD. Eur Respir Rev. 2014;23:345–9.
  22. Atlantis E, Fahey P, Cochrane B, Smith S. Bidirectional associations between clinically relevant depression or anxiety and COPD: A systematic review and meta-analysis. Chest. 2013;144:766–77.
  23. Martínez-Gestoso S, García-Sanz MT, Carreira JM, Salgado FJ, Calvo-Álvarez U, Doval-Oubiña L, et al. Impact of anxiety and depression on the prognosis of copd exacerbations. BMC Pulm Med. 2022;22:169.
  24. Rahi MS, Thilagar B, Balaji S, Prabhakaran SY, Mudgal M, Rajoo S, et al. The impact of anxiety and depression in Chronic Obstructive Pulmonary Disease. Adv Respir Med. 2023;91:123–34.
  25. Garvey C, Criner GJ. Impact of comorbidities on the treatment of Chronic Obstructive Pulmonary Disease. Am J Med. 2018;131:23–9.
  26. Alharbi R, Alsuhaibani K, Almarshad A, Alyahya A. Depression and anxiety among high school student at Qassim Region. J Family Med Prim Care. 2019;8:504–10.
  27. Huang K, Huang K, Xu J, Yang L, Zhao J, Zhang X, et al. Anxiety and depression in patients with Chronic Obstructive Pulmonary Disease in China: Results from the China Pulmonary Health [CPH] study. Int J Chron Obstruct Pulmon Dis. 2021;16:3387–96.
  28. Dregan A, Matcham F, Harber-Aschan L, Rayner L, Brailean A, Davis K, et al. Common mental disorders within chronic inflammatory disorders: A primary care database prospective investigation. Ann Rheum Dis. 2019;78:688–95.
  29. Lee AL, Goldstein RS, Brooks D. Chronic pain in people with Chronic Obstructive Pulmonary Disease: Prevalence, clinical and psychological implications. Chronic Obstr Pulm Dis. 2017;4:194–203.
  30. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34:648–54.
  31. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.
  32. Naylor SD, Haines J, Vyas A, Fowler SJ. M3 anxiety and depression in patients with breathing pattern disorders or chronic respiratory disease. Thorax. 2015;70:A227–8.
  33. Alamoudi OS. Prevalence of respiratory diseases in hospitalized patients in Saudi Arabia: A 5 years study 1996-2000. Ann Thorac Med. 2006;1:76–80.
  34. López-Pintor E, Grau J, González I, Bernal-Soriano MC, Quesada JA, Lumbreras B. Impact of patients' perception of COPD and treatment on adherence and health-related quality of life in real-world: Study in 53 community pharmacies. Respir Med. 2021;176:106280.
  35. Ovcharenko S, Galetskayte Y, Romanov D, Petelin D, Volel B. Identification of different profiles of illness perception in COPD patients: Results of cluster analysis. Open Respir Med J. 2022;16:e187430642112141.
  36. Kourlaba G, Hillas G, Vassilakopoulos T, Maniadakis N. The disease burden of chronic obstructive pulmonary disease in Greece. Int J Chron Obstruct Pulmon Dis. 2016;11:2179–89.
  37. Kessler R, Partridge MR, Miravitlles M, Cazzola M, Vogelmeier C, Leynaud D, et al. Symptom variability in patients with severe COPD: A pan-European cross-sectional study. Eur Respir J. 2011;37:264–72.
  38. Anguzu R, Nagavally S, Dawson AZ, Walker RJ, Egede LE. Age and gender differences in trends and impact of depression on quality of life in the United States, 2008 to 2016. Womens Health Issues. 2021;31:353–65.
  39. Gigantesco A, Fagnani C, Toccaceli V, Stazi MA, Lucidi F, Violani C, et al. The relationship between satisfaction with life and depression symptoms by gender. Front Psychiatry. 2019;10:419.
  40. Kennair LEO, Hagen R, Hjemdal O, Havnen A, Ryum T, Solem S. Depression, anxiety, insomnia, and quality of life in a representative community sample of older adults living at home. Front Psychol. 2022;13:811082.
  41. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2020 report). Global Initiative for Chronic Obstructive Lung Disease, 2020.
  42. Xiao T, Qiu H, Chen Y, Zhou X, Wu K, Ruan X, et al. Prevalence of anxiety and depression symptoms and their associated factors in mild COPD patients from community settings, Shanghai, China: A cross-sectional study. BMC Psychiatry. 2018;18:89.
  43. Yohannes AM, Kaplan A, Hanania NA. Anxiety and depression in Chronic Obstructive Pulmonary Disease: Recognition and management. Cleve Clin J Med. 2018;85:S11–8.
  44. Pumar MI, Gray CR, Walsh JR, Yang IA, Rolls TA, Ward DL. Anxiety and depression-Important psychological comorbidities of COPD. J Thorac Dis. 2014;6:1615–31.

Creative Commons License

Creative Commons Attribution-Share Alike 3.0 License
This work is licensed under a Creative Commons Attribution-Share Alike 3.0 License.

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.